Brazil · Delayed Price · Currency is BRL Revance Therapeutics Statistics
Total Valuation
BVMF:BMOB3 has a market cap or net worth of BRL 1.70 billion. The enterprise value is 1.19 billion.
| Market Cap | 1.70B |
| Enterprise Value | 1.19B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Apr 25, 2025 |
Share Statistics
BVMF:BMOB3 has 84.22 million shares outstanding. The number of shares has decreased by -0.74% in one year.
| Current Share Class | 84.22M |
| Shares Outstanding | 84.22M |
| Shares Change (YoY) | -0.74% |
| Shares Change (QoQ) | -1.52% |
| Owned by Insiders (%) | 5.41% |
| Owned by Institutions (%) | 16.05% |
| Float | 38.09M |
Valuation Ratios
The trailing PE ratio is 13.42 and the forward PE ratio is 10.66.
| PE Ratio | 13.42 |
| Forward PE | 10.66 |
| PS Ratio | 1.11 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 18.23 |
| P/OCF Ratio | 11.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.17, with an EV/FCF ratio of 12.73.
| EV / Earnings | 9.24 |
| EV / Sales | 0.78 |
| EV / EBITDA | 9.17 |
| EV / EBIT | 9.98 |
| EV / FCF | 12.73 |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.65 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.03 |
| Interest Coverage | 160.03 |
Financial Efficiency
Return on equity (ROE) is 11.39% and return on invested capital (ROIC) is 6.53%.
| Return on Equity (ROE) | 11.39% |
| Return on Assets (ROA) | 4.84% |
| Return on Invested Capital (ROIC) | 6.53% |
| Return on Capital Employed (ROCE) | 9.77% |
| Revenue Per Employee | 1.92M |
| Profits Per Employee | 160,971 |
| Employee Count | 800 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 57.47 |
Taxes
In the past 12 months, BVMF:BMOB3 has paid 40.88 million in taxes.
| Income Tax | 40.88M |
| Effective Tax Rate | 23.97% |
Stock Price Statistics
The stock price has increased by +48.61% in the last 52 weeks. The beta is 0.54, so BVMF:BMOB3's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +48.61% |
| 50-Day Moving Average | 20.51 |
| 200-Day Moving Average | 16.57 |
| Relative Strength Index (RSI) | 44.51 |
| Average Volume (20 Days) | 323,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVMF:BMOB3 had revenue of BRL 1.53 billion and earned 128.78 million in profits. Earnings per share was 1.51.
| Revenue | 1.53B |
| Gross Profit | 359.82M |
| Operating Income | 119.22M |
| Pretax Income | 170.49M |
| Net Income | 128.78M |
| EBITDA | 127.24M |
| EBIT | 119.22M |
| Earnings Per Share (EPS) | 1.51 |
Balance Sheet
The company has 520.44 million in cash and 2.92 million in debt, giving a net cash position of 517.52 million or 6.15 per share.
| Cash & Cash Equivalents | 520.44M |
| Total Debt | 2.92M |
| Net Cash | 517.52M |
| Net Cash Per Share | 6.15 |
| Equity (Book Value) | 1.17B |
| Book Value Per Share | 13.81 |
| Working Capital | 672.71M |
Cash Flow
In the last 12 months, operating cash flow was 146.46 million and capital expenditures -52.99 million, giving a free cash flow of 93.47 million.
| Operating Cash Flow | 146.46M |
| Capital Expenditures | -52.99M |
| Free Cash Flow | 93.47M |
| FCF Per Share | 1.11 |
Margins
Gross margin is 23.47%, with operating and profit margins of 7.78% and 8.40%.
| Gross Margin | 23.47% |
| Operating Margin | 7.78% |
| Pretax Margin | 11.12% |
| Profit Margin | 8.40% |
| EBITDA Margin | 8.30% |
| EBIT Margin | 7.78% |
| FCF Margin | 6.10% |
Dividends & Yields
This stock pays an annual dividend of 0.64, which amounts to a dividend yield of 3.18%.
| Dividend Per Share | 0.64 |
| Dividend Yield | 3.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 70.81% |
| Buyback Yield | 0.74% |
| Shareholder Yield | 3.90% |
| Earnings Yield | 7.56% |
| FCF Yield | 5.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BVMF:BMOB3 has an Altman Z-Score of 3.42 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.42 |
| Piotroski F-Score | 6 |